The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
| Member | Definition | Class |
|---|
| (e)-4-hydroxy-3-methylbut-2-enyl diphosphate | A prenol phosphate comprising (2E)-4-hydroxy-3-methylbut-2-en-1-ol having an O-diphosphate substituent. | (2E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate |
| (n-(p-cyanophenyl)-n'-(diphenylmethyl)guanidine)acetic acid | A trisubstituted guanidine, carrying 4-cyanophenyl, diphenylmethyl and carboxymethyl substituents, which is known to act as a highly potent sweetening agent. | [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid |
| 1-lauryl-2-pyrrolidone | Pyrrolidin-2-one substituted at nitrogen by an n-dodecyl group. | 1-dodecylpyrrolidin-2-one |
| 15-acetyldeoxynivalenol | A trichothecene mycotoxin that is deoxynivalenol acetylated on the oxygen at C-15. A skin and eye irritant, along with its 3-acetyl regioisomer and its parent deoxynivalenol it is considered among the most commonly and widely distributed cereal contaminants. | 15-acetyldeoxynivalenol |
| 2-acetylaminofluorene | The parent of the class of 2-acetamidofluorenes, being an ortho-fused polycyclic arene that consists of 9H-fluorene bearing an acetamido substituent at position 2. It is a carcinogenic and mutagenic derivative of fluorene. | 2-acetamidofluorene |
| 3-acetyldeoxynivalenol | A trichothecene mycotoxin that is deoxynivalenol acetylated on the oxygen at C-3. A skin and eye irritant, along with its 15-acetyl regioisomer and its parent deoxynivalenol it is considered among the most commonly and widely distributed cereal contaminants. | 3-acetyldeoxynivalenol |
| 3,3-dimethylallyl pyrophosphate | A prenol phosphate that is a phosphoantigen comprising the O-pyrophosphate of prenol. | prenyl diphosphate |
| 3,4-dichloroaniline | A dichloroaniline having the two chloro-substituents at the 3- and 4-positions. | 3,4-dichloroaniline |
| 4-nitrophenylphosphorylcholine | A phosphocholine that is the 4-nitrophenyl ester of choline phosphate. | p-nitrophenylphosphocholine |
| acenaphthenequinone | An orthoquinone that is the 1,2-dioxo derivative of acenaphthene. | acenaphthoquinone |
| acetylgalactosamine | An N-acetyl-D-galactosamine having beta-configuration at the anomeric centre. | N-acetyl-beta-D-galactosamine |
| acetylglucosamine | An N-acetyl-D-glucosamine having beta-configuration at the anomeric centre. | N-acetyl-beta-D-glucosamine |
| alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc | A branched amino tetrasaccharide consisting of a sialyl residue, linked (2->3) to a galactosyl residue that in turn is linked (1->4) to a glucosaminyl residue, which is also carrying a fucosyl residue at the 3-position. | 3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc.html>alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc |
| argpyrimidine | A member of the class of hydroxypyrimidines obtained by cyclocondensation of L-arginine and methylglyoxal; a methyl glyoxal-derived advanced glycation end-product (AGE) in familial amyloidotic polyneuropathy and human cancers. | argpyrimidine |
| benzoylecgonine | A benzoate ester metabolite of cocaine formed by hydrolysis of the methyl ester group, catalysed by carboxylesterases. | ecgonine benzoate |
| benzyl cinnamate | The cinnamate ester derived from cinnamic acid and benzyl alcohol. Occuring in Balsam of Peru and Tolu balsam, in Sumatra and Penang benzoin, and as the main constituent of copaiba balsam, it is used in heavy oriental perfumes, as a fixative and as a flavouring agent. | benzyl cinnamate |
| beryllium | Alkaline earth metal atom with atomic number 4. | beryllium atom; beryllium(0) |
| blood group a trisaccharide | A branched amino trisaccharide consisting of beta-D-galactose having an alpha-L-fucosyl residue at the 2-position and an N-acetyl-alpha-D-galactosaminyl residue at the 3-position. | 3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp.html>alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp |
| blood group b trisaccharide | A branched trisaccharide consisting of beta-D-galactose having an alpha-L-fucosyl residue at the 2-position and an alpha-D-galactosyl residue at the 3-position. | 2)-[alpha-D-Gal-(1->3)]-beta-D-Gal.html>alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal |
| cellobiose | A cellobiose with beta configuration at the reducing-end glucose residue. | beta-cellobiose |
| dansyllysine | An L-lysine derivative with a dansyl group at the N(6)-position. | N(6)-dansyl-L-lysine |
| digoxin | A cardenolide glycoside that is digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small. | digoxin |
| dinitrochlorobenzene | A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions. | 1-chloro-2,4-dinitrobenzene |
| dronabinol | A diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. The principal psychoactive constituent of the cannabis plant, it is used for treatment of anorexia associated with AIDS as well as nausea and vomiting associated with cancer chemotherapy. | Delta(9)-tetrahydrocannabinol |
| estriol 3-glucuronide | A steroid glucosiduronic acid that is the 3-beta-D-glucuronide of estriol; a steroid hormone ligand recognised by the monoclonal antibody 4155. | estriol 3-O-(beta-D-glucuronide) |
| fees | A glycophytoceramide comprising (2S,3S,4R)-2-aminononane-1,3,4-triol having an alpha-D-galctopyranosyl residue at the O-1 position and an tetracosanoyl group attached to the nitrogen. | 1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol |
| fixb protein, e coli | D-Mannopyranose having alpha-configuration at the anomeric centre. | alpha-D-mannose |
| flucofuron | A member of the class of phenylureas that is urea in which each nitrogen is substituted by a 4-chloro-3-(trifluoromethyl)phenyl group. | flucofuron |
| g(m1)-oligosaccharide | A branched amino pentasaccharide consisting of the linear sequence beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc having a Neu5Ac residue attached to the inner galactose via an alpha-(2->3) linkage. The oligosaccharide of ganglioside GM1a. | 3)-beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->4)-beta-D-Glcp.html>beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->4)-beta-D-Glcp |
| galactose | A D-galactopyranose having beta-configuration at the anomeric centre. | beta-D-galactose |
| globo-h | An amino trisaccharide consisting of alpha-L-fucose, beta-D-galactose and N-acetyl-beta-D-glucosamine residues joined by sequential (1->2)- and (1->3)-linkages. | 2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc.html>alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc |
| glucose, (beta-d)-isomer | D-Glucopyranose with beta configuration at the anomeric centre. | beta-D-glucose |
| hemoglobin randwick | A D-mannopyranose in which the anomeric centre has beta-configuration. | beta-D-mannose |
| inositol cyclic phosphate | A myo-inositol cyclic phosphate that is the 1,2-cyclic phosphate derivative of 1D-myo-inositol. | 1D-myo-inositol 1,2-cyclic phosphate |
| isopentenyl pyrophosphate | A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent. | isopentenyl diphosphate |
| krn 7000 | A glycophytoceramide having an alpha-D-galactosyl residue at the O-1 position and a hexacosanoyl group attached to the nitrogen. | 1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine |
| marinobufagenin | A cardiotonic steroid secreted by the toad Bufo rubescens and other related species such as Bufo marinus. An endogenous Na/K-ATPase inhibitor, it is a vasoconstrictor with effects similar to digitalis. | marinobufagenin |
| methacholine | A quaternary ammonium ion in which the nitrogen is substituted with three methyl groups and a 2-acetoxypropyl group. Parasympathomimetic bronchoconstrictor drug used in clinical diagnosis. | methacholine |
| methylphosphate | A monoalkyl phosphate having methyl as the alkyl group. | methyl dihydrogen phosphate |
| monoethyl phosphate | A monoalkyl phosphate epitope having ethyl as the alkyl group. | ethyl dihydrogen phosphate |
| N-acetyl-alpha-D-galactosamine | An N-acetyl-D-galactosamine having alpha-configuration at the anomeric centre. | N-acetyl-alpha-D-galactosamine |
| N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose | An amino trisaccharide that is the carbohydrate portion of ganglioside GM3. It comprises a linear sequence of alpha-N-acetylneuraminyl, beta-D-galactosyl and beta-D-glucose residues linked (2->3) and (1->4). | 3)-beta-D-galactosyl-(1->4)-beta-D-glucose.html>N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose |
| n-acetylneuraminic acid | N-Acetylneuraminic acid with beta configuration at the anomeric centre. | N-acetyl-beta-neuraminic acid |
| n-acetylneuraminosyl(alpha2-6)lactosamine | An amino trisaccharide consisting of an N-acetyl-alpha-neuraminyl residue attached to the galactose residue of N-acetyllactosamine via an alpha-(2->6)-linkage. | 6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine.html>alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine |
| nickel | Chemical element (nickel group element atom) with atomic number 28. | nickel atom |
| o-phthalaldehyde | A dialdehyde in which two formyl groups are attached to adjacent carbon centres on a benzene ring. | phthalaldehyde |
| oregon green 488 carboxylic acid | A xanthene dye having two fluoro substituents at the 2- and 7-positions and a 2,4-dicarboxyphenyl group at the 9-position. | oregon green 488 |
| ornidazole | A C-nitro compound that is 5-nitroimidazole in which the hydrogens at positions 1 and 2 are replaced by 3-chloro-2-hydroxypropyl and methyl groups, respectively. It is used in the treatment of susceptible protozoal infections and for the treatment of anaerobic bacterial infections. | ornidazole |
| penicillin g | A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. | benzylpenicillin |
| phosphorylcholine | The phosphate of choline; and the parent compound of the phosphocholine family. | phosphocholine |
| picryl chloride | The C-nitro compound that is chlorobenzene with three nitro substituents in the 2-, 4- and 6-positions. | 1-chloro-2,4,6-trinitrobenzene |
| s-adenosylhomocysteine | An organic sulfide that is the S-adenosyl derivative of L-homocysteine. | S-adenosyl-L-homocysteine zwitterion; S-adenosyl-L-homocysteine |
| secnidazole | A C-nitro compound that is 5-nitroimidazole in which the hydrogens at positions 1 and 2 are replaced by 2-hydroxypropyl and methyl groups, respectively. | 1-(2-methyl-5-nitro-1-imidazolyl)-2-propanol; secnidazole |
| sulfamethoxazole | An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position. | sulfamethoxazole |
| trimellitic anhydride | A 2-benzofuran compound having oxo groups at the 1- and 3-positions and a carboxy substituent at the 5-position; the cyclic anhydride formed from the carboxy groups at the 1- and 2-positions of trimellitic acid. | trimellitic anhydride |
| trinitrobenzenesulfonic acid | The arenesulfonic acid that is benzenesulfonic acid with three nitro substituents in the 2-, 4- and 6-positions. | 2,4,6-trinitrobenzenesulfonic acid |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 67.9K protein | Vaccinia virus | Potency | 21.3156 | 2 | 3 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 50.9169 | 2 | 4 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 16.1424 | 1 | 8 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 24.4354 | 1 | 2 |
| alpha-galactosidase | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 39.8107 | 1 | 1 |
| AR protein | Homo sapiens (human) | Potency | 15.1824 | 12 | 79 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 39.1158 | 3 | 15 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 17.1163 | 2 | 5 |
| Ataxin-2 | Homo sapiens (human) | Potency | 14.9313 | 1 | 11 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 42.5615 | 1 | 1 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 15.0200 | 2 | 18 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 44.6684 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 51.7866 | 1 | 5 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 21.6899 | 1 | 1 |
| caspase-3 | Homo sapiens (human) | Potency | 51.7866 | 1 | 5 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 21.6899 | 1 | 1 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 18.5810 | 3 | 21 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 0.1790 | 2 | 2 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 3.9811 | 1 | 1 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 16.0935 | 2 | 4 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 22.4748 | 1 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 79.4328 | 1 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 32.3105 | 1 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 2.2334 | 1 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 26.9680 | 2 | 2 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 72.6796 | 1 | 2 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 12.3018 | 1 | 1 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 25.1189 | 2 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 3.6822 | 2 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 8.8391 | 1 | 8 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 46.6794 | 1 | 3 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 23.7781 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 22.0215 | 12 | 89 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 31.5829 | 2 | 12 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 22.0822 | 6 | 64 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 29.7544 | 1 | 4 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 32.6425 | 3 | 3 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 29.0409 | 5 | 19 |
| G | Vesicular stomatitis virus | Potency | 12.3018 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| geminin | Homo sapiens (human) | Potency | 7.7963 | 2 | 16 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 20.8922 | 3 | 22 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| GLS protein | Homo sapiens (human) | Potency | 6.4092 | 2 | 2 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 22.7965 | 5 | 28 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 18.8142 | 1 | 9 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 44.6684 | 1 | 1 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 23.0807 | 2 | 9 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 33.6862 | 2 | 2 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 52.3758 | 2 | 5 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 12.3018 | 1 | 1 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 20.5262 | 2 | 6 |
| IDH1 | Homo sapiens (human) | Potency | 6.5100 | 1 | 3 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 125.8920 | 1 | 1 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 12.3018 | 1 | 2 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 0.1995 | 1 | 1 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 0.1995 | 1 | 1 |
| Interferon beta | Homo sapiens (human) | Potency | 3.1032 | 2 | 4 |
| interleukin 8 | Homo sapiens (human) | Potency | 33.5614 | 1 | 2 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 5.7118 | 1 | 4 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 0.0316 | 1 | 1 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 31.0779 | 2 | 6 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 8.9125 | 1 | 1 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 5.0119 | 1 | 1 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 24.8033 | 1 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 0.2239 | 1 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 16.2995 | 4 | 23 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 8.7057 | 2 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 34.5705 | 2 | 7 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 9.4392 | 1 | 1 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 2.1859 | 2 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 24.8530 | 3 | 33 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 4.4668 | 1 | 2 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 40.5334 | 1 | 1 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 16.6431 | 5 | 26 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 15.9584 | 5 | 17 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 11.2202 | 1 | 1 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 1.2589 | 1 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 35.4813 | 1 | 2 |
| PPM1D protein | Homo sapiens (human) | Potency | 0.0370 | 1 | 2 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 27.5039 | 3 | 13 |
| progesterone receptor | Homo sapiens (human) | Potency | 24.3092 | 3 | 14 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 79.4328 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 11.8391 | 2 | 24 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 0.2528 | 1 | 2 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 1.2636 | 1 | 2 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 19.2608 | 3 | 26 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 13.7267 | 4 | 21 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 7.0795 | 1 | 1 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 13.0856 | 2 | 8 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 13.0856 | 2 | 8 |
| Smad3 | Homo sapiens (human) | Potency | 3.2752 | 1 | 3 |
| snurportin-1 | Homo sapiens (human) | Potency | 125.8920 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 5.0119 | 1 | 1 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 14.5015 | 1 | 2 |
| TDP1 protein | Homo sapiens (human) | Potency | 5.9082 | 2 | 17 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 3.1099 | 1 | 2 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 2.8184 | 1 | 2 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 21.5095 | 2 | 19 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 26.0233 | 4 | 6 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 23.3454 | 6 | 20 |
| tumor necrosis factor | Homo sapiens (human) | Potency | 0.3758 | 1 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 43.2397 | 1 | 1 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 1.2589 | 1 | 1 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 1.2589 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 30.0594 | 1 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 31.2520 | 2 | 8 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 17.9139 | 5 | 18 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 18.8142 | 1 | 9 |
| Vpr | Human immunodeficiency virus 1 | Potency | 18.5482 | 1 | 2 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 17beta-hydroxysteroid dehydrogenase | Curvularia lunata | IC50 | 3.8500 | 2 | 2 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli | IC50 | 28.5000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 4.7000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 3.1700 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 2.0170 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 2.1430 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 1.1220 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 2.1430 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 1.1220 | 1 | 1 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 100.0000 | 2 | 2 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 8.5950 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 8.5240 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 21.0610 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 7.8980 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 0.0590 | 1 | 1 |
| Asialoglycoprotein receptor 1 | Homo sapiens (human) | IC50 | 15,524.5000 | 1 | 2 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 2 |
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | IC50 | 57.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 50.0000 | 3 | 3 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 50.0000 | 4 | 4 |
| Beta-lactamase TEM | Escherichia coli | Ki | 20.0000 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 279.1833 | 3 | 6 |
| Butyrophilin subfamily 3 member A1 | Homo sapiens (human) | IC50 | 104.1667 | 10 | 12 |
| C-type lectin domain family 4 member M | Homo sapiens (human) | IC50 | 3,386.0000 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 2 |
| Cannabinoid receptor 1 | Homo sapiens (human) | IC50 | 0.0028 | 1 | 1 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 1.3649 | 2 | 2 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 0.0295 | 18 | 18 |
| Cannabinoid receptor 1 | Mus musculus (house mouse) | Ki | 0.0405 | 2 | 2 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 0.0468 | 10 | 10 |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 0.2180 | 1 | 1 |
| Cannabinoid receptor 2 | Mus musculus (house mouse) | Ki | 0.0303 | 3 | 4 |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | Ki | 0.0460 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | IC50 | 0.0095 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 0.0366 | 22 | 22 |
| CD209 antigen | Homo sapiens (human) | IC50 | 6,400.0000 | 1 | 1 |
| Chain 1, Mannose-binding Protein-c | Rattus rattus (black rat) | Ki | 5,700.0000 | 1 | 4 |
| Chain A, Endoglucanase B | Salipaludibacillus agaradhaerens | Ki | 4,500.0000 | 1 | 1 |
| Chain A, Ermc' Methyltransferase | Bacillus subtilis | Ki | 33.0000 | 1 | 1 |
| Chain A, Ermc' Rrna Methyltransferase | Bacillus subtilis | Ki | 33.0000 | 1 | 1 |
| Chain A, Histamine N-Methyltransferase | Homo sapiens (human) | Ki | 6.9000 | 1 | 2 |
| Chain A, Isopentenyl-diphosphate delta-isomerase | Escherichia coli | IC50 | 50.0000 | 1 | 1 |
| Chain A, Uroporphyrin-III C-methyltransferase | Pseudomonas denitrificans (nom. rej.) | Ki | 0.3200 | 1 | 1 |
| Chain B, lectin I B chain | Viscum album (European mistletoe) | IC50 | 900.0000 | 1 | 1 |
| Cholinesterase | Homo sapiens (human) | Ki | 21.2282 | 3 | 5 |
| Coagulation factor XII | Homo sapiens (human) | Ki | 1.0570 | 1 | 3 |
| Cocaine esterase | Homo sapiens (human) | Ki | 0.1700 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 0.0160 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 25.9976 | 2 | 2 |
| Dihydrofolate reductase | Pneumocystis carinii | IC50 | 0.1000 | 1 | 1 |
| Dihydropteroate synthase | Escherichia coli K-12 | IC50 | 4.7000 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | IC50 | 1.4212 | 10 | 10 |
| DNA (cytosine-5)-methyltransferase 3A | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 3B | Homo sapiens (human) | IC50 | 10.2900 | 5 | 5 |
| Early activation antigen CD69 | Homo sapiens (human) | IC50 | 480.7070 | 3 | 3 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | IC50 | 223.3333 | 3 | 3 |
| exodeoxyribonuclease V subunit RecB | Escherichia coli str. K-12 substr. MG1655 | IC50 | 106.4380 | 2 | 2 |
| exodeoxyribonuclease V subunit RecC | Escherichia coli str. K-12 substr. MG1655 | IC50 | 106.4380 | 2 | 2 |
| exodeoxyribonuclease V subunit RecD | Escherichia coli str. K-12 substr. MG1655 | IC50 | 106.4380 | 2 | 2 |
| Fatty acid synthase | Homo sapiens (human) | Ki | 150.0000 | 1 | 1 |
| Fatty acid-binding protein, liver | Mus musculus (house mouse) | Ki | 1.0000 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | IC50 | 43.6000 | 1 | 1 |
| G-protein coupled receptor 55 | Homo sapiens (human) | IC50 | 14.2000 | 1 | 1 |
| Glutathione S-transferase omega-1 | Homo sapiens (human) | IC50 | 900.0000 | 1 | 1 |
| Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | Ki | 7,400.0000 | 1 | 1 |
| Histamine N-methyltransferase | Homo sapiens (human) | Ki | 14.3000 | 1 | 2 |
| Histone-arginine methyltransferase CARM1 | Homo sapiens (human) | Ki | 0.6300 | 2 | 2 |
| Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | IC50 | 1.5120 | 2 | 2 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 0.2300 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 2.6400 | 3 | 3 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | Ki | 0.5700 | 1 | 1 |
| Histone-lysine N-methyltransferase EZH1 | Homo sapiens (human) | IC50 | 6.4000 | 1 | 1 |
| Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | IC50 | 24.8400 | 5 | 5 |
| Histone-lysine N-methyltransferase KMT5C | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Histone-lysine N-methyltransferase NSD2 | Homo sapiens (human) | IC50 | 39.1000 | 1 | 1 |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | IC50 | 38.5000 | 2 | 2 |
| Histone-lysine N-methyltransferase SETDB1 | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| Histone-lysine N-methyltransferase SUV39H1 | Homo sapiens (human) | IC50 | 1.2000 | 1 | 1 |
| Histone-lysine N-methyltransferase SUV39H1 | Homo sapiens (human) | Ki | 4.9000 | 1 | 1 |
| Histone-lysine N-methyltransferase SUV39H2 | Homo sapiens (human) | IC50 | 27.0000 | 2 | 2 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | IC50 | 0.3900 | 4 | 4 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | Ki | 0.1967 | 3 | 3 |
| Indolethylamine N-methyltransferase | Homo sapiens (human) | Ki | 2.0000 | 1 | 2 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | IC50 | 1,425.0000 | 1 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | Ki | 57.0000 | 1 | 1 |
| Killer cell lectin-like receptor subfamily B member 1A | Rattus norvegicus (Norway rat) | IC50 | 2.2536 | 2 | 2 |
| L-lactate dehydrogenase A chain | Homo sapiens (human) | Ki | 14.0000 | 1 | 1 |
| Liver carboxylesterase 1 | Homo sapiens (human) | Ki | 0.6466 | 3 | 5 |
| Lysophosphatidylserine lipase ABHD12 | Homo sapiens (human) | IC50 | 11.6000 | 1 | 1 |
| Methylosome protein 50 | Homo sapiens (human) | IC50 | 0.5800 | 2 | 2 |
| Monoacylglycerol lipase ABHD6 | Homo sapiens (human) | IC50 | 48.2000 | 1 | 1 |
| Monoglyceride lipase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 2.7900 | 2 | 2 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | IC50 | 3.5933 | 2 | 3 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 0.0590 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | Ki | 0.0590 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | IC50 | 0.7000 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | Ki | 1.6000 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | Ki | 1.6000 | 1 | 1 |
| N-lysine methyltransferase SMYD2 | Homo sapiens (human) | IC50 | 0.1800 | 1 | 1 |
| N6-adenosine-methyltransferase catalytic subunit | Homo sapiens (human) | IC50 | 0.5900 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | 1,000.0000 | 1 | 1 |
| Neuraminidase | Influenza B virus (B/Lee/1940) | IC50 | 1,000.0000 | 1 | 1 |
| Nicotinamide N-methyltransferase | Homo sapiens (human) | IC50 | 35.3000 | 1 | 1 |
| Non-structural protein 1 | Dengue virus | IC50 | 0.4900 | 1 | 1 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | IC50 | 16.6419 | 10 | 10 |
| Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | Ki | 45.6500 | 1 | 2 |
| Phenylethanolamine N-methyltransferase | Homo sapiens (human) | Ki | 14.0000 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | Ki | 0.0101 | 1 | 1 |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | IC50 | 0.4300 | 4 | 4 |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | Ki | 0.4000 | 1 | 1 |
| Protein arginine N-methyltransferase 3 | Homo sapiens (human) | IC50 | 0.9567 | 3 | 3 |
| Protein arginine N-methyltransferase 5 | Homo sapiens (human) | IC50 | 12.8400 | 4 | 4 |
| Protein arginine N-methyltransferase 7 | Homo sapiens (human) | IC50 | 25.0550 | 2 | 2 |
| Protein dpy-30 homolog | Homo sapiens (human) | IC50 | 0.7240 | 1 | 1 |
| Protein-arginine deiminase type-4 | Homo sapiens (human) | IC50 | 10,000.0000 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 0.1900 | 1 | 1 |
| Retinoblastoma-binding protein 5 | Homo sapiens (human) | IC50 | 0.7240 | 1 | 1 |
| rRNA adenine N-6-methyltransferase | Streptococcus pneumoniae | Ki | 40.0000 | 2 | 2 |
| Set1/Ash2 histone methyltransferase complex subunit ASH2 | Homo sapiens (human) | IC50 | 0.7240 | 1 | 1 |
| Sialic acid-binding Ig-like lectin 7 | Homo sapiens (human) | IC50 | 36,900.0000 | 1 | 1 |
| Sialidase-1 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-3 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-4 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | Homo sapiens (human) | IC50 | 55.7000 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 8.5950 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 8.5240 | 1 | 1 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 6.0530 | 1 | 1 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 3.2160 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | Canis lupus familiaris (dog) | IC50 | 0.5000 | 2 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | Homo sapiens (human) | IC50 | 0.3200 | 3 | 3 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | Homo sapiens (human) | Ki | 0.1220 | 1 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | Homo sapiens (human) | IC50 | 0.3350 | 2 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.2200 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | Homo sapiens (human) | Ki | 0.1220 | 1 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | Homo sapiens (human) | IC50 | 0.3350 | 2 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.2200 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | Homo sapiens (human) | IC50 | 0.3350 | 2 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 0.0055 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | Homo sapiens (human) | IC50 | 0.3350 | 2 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | Homo sapiens (human) | Ki | 0.1220 | 1 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0055 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | Homo sapiens (human) | IC50 | 0.3350 | 2 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-3 | Homo sapiens (human) | IC50 | 0.3350 | 2 | 2 |
| Sodium/potassium-transporting ATPase subunit gamma | Homo sapiens (human) | IC50 | 0.3350 | 2 | 2 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | Ki | 30,000.0000 | 2 | 2 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | Ki | 10,982.4000 | 1 | 2 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 11,100.0000 | 1 | 1 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 1,049.0000 | 2 | 2 |
| Solute carrier family 22 member 8 | Mus musculus (house mouse) | IC50 | 89.4000 | 1 | 1 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | Ki | 97.6000 | 1 | 1 |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | Ki | 52.8000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | Ki | 0.3085 | 2 | 2 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 3.2359 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 13.1826 | 1 | 1 |
| STAT3, partial | Homo sapiens (human) | IC50 | 1.8620 | 1 | 1 |
| tRNA (cytosine(38)-C(5))-methyltransferase | Homo sapiens (human) | IC50 | 15.8000 | 1 | 1 |
| WD repeat-containing protein 5 | Homo sapiens (human) | IC50 | 0.7240 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| Asialoglycoprotein receptor 1 | Homo sapiens (human) | Kd | 5,730.0000 | 1 | 2 |
| Butyrophilin subfamily 3 member A1 | Homo sapiens (human) | EC50 | 9.1256 | 8 | 12 |
| Butyrophilin subfamily 3 member A1 | Homo sapiens (human) | Kd | 2.9050 | 2 | 2 |
| Cannabinoid receptor 1 | Homo sapiens (human) | EC50 | 0.0458 | 3 | 3 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 0.0738 | 2 | 3 |
| Cannabinoid receptor 2 | Mus musculus (house mouse) | EC50 | 0.0073 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | EC50 | 0.0086 | 3 | 3 |
| Chain 1, MANNOSE-BINDING PROTEIN-A | Rattus norvegicus (Norway rat) | Kd | 200.0000 | 1 | 1 |
| Chain A, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI | Thermus aquaticus | Kd | 2.4000 | 1 | 2 |
| Chain A, Agglutinin alpha chain | Artocarpus integer | Kd | 820.0000 | 1 | 3 |
| Chain A, Antigen-presenting glycoprotein CD1d1 | Mus musculus (house mouse) | Kd | 0.2340 | 1 | 5 |
| Chain A, cellulase | Phanerodontia chrysosporium | Kd | 115.0000 | 1 | 2 |
| Chain A, Cellulose 1,4-beta-cellobiosidase | Melanocarpus albomyces | Kd | 6.0000 | 1 | 1 |
| Chain A, Discoidin-2 | Dictyostelium discoideum AX2 | Kd | 1,150.0000 | 1 | 2 |
| Chain A, Galacto-N-biose/lacto-N-biose I transporter substrate-binding protein | Bifidobacterium longum | Kd | 0.0100 | 1 | 1 |
| Chain A, GLUCOSE/GALACTOSE-BINDING PROTEIN | Salmonella enterica subsp. enterica serovar Typhimurium | Kd | 0.2000 | 1 | 1 |
| Chain A, L-ARABINOSE-BINDING PROTEIN | Escherichia coli | Kd | 0.0100 | 1 | 3 |
| Chain A, Lectin | Erythrina corallodendron | Kd | 662.5556 | 1 | 9 |
| Chain A, Modification Methylase Rsri | Cereibacter sphaeroides | Kd | 8.1000 | 1 | 2 |
| Chain A, Pea Lectin | Pisum sativum (garden pea) | Kd | 700.0000 | 1 | 1 |
| Chain A, PROBABLE SUGAR ABC TRANSPORTER, SUGAR-BINDING PROTEIN | Streptococcus pneumoniae SP3-BS71 | Kd | 0.8300 | 1 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase | Pisum sativum (garden pea) | Kd | 21.2000 | 1 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase | Pisum sativum (garden pea) | Kd | 21.2000 | 1 | 3 |
| Chain A, T-cell surface glycoprotein CD1d1 | Mus musculus (house mouse) | Kd | 0.0068 | 1 | 1 |
| Chain A, Undecaprenyl pyrophosphate synthetase | Escherichia coli | Kd | 520.0000 | 1 | 1 |
| Chain B, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI | Thermus aquaticus | Kd | 2.4000 | 1 | 1 |
| Chain B, Agglutinin beta-3 chain | Artocarpus integer | Kd | 820.0000 | 1 | 1 |
| Chain B, Pea Lectin | Pisum sativum (garden pea) | Kd | 700.0000 | 1 | 1 |
| Chain C, Agglutinin alpha chain | Artocarpus integer | Kd | 820.0000 | 1 | 1 |
| Chain C, NKT Valpha14-Jalpha18,NKT Valpha14-Jalpha18 | Mus musculus (house mouse) | Kd | 0.2340 | 1 | 5 |
| Chain D, Agglutinin beta-3 chain | Artocarpus integer | Kd | 820.0000 | 1 | 1 |
| Chain H, Protein (antibody M3c65 (heavy Chain)) | Mus musculus (house mouse) | Kd | 0.3200 | 1 | 1 |
| Chain L, Protein (antibody M3c65 (light Chain)) | Mus musculus (house mouse) | Kd | 0.3200 | 1 | 1 |
| D(3) dopamine receptor | Homo sapiens (human) | EC50 | 0.0102 | 1 | 1 |
| G-protein coupled receptor 55 | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| Galectin-8 | Homo sapiens (human) | Kd | 2.3000 | 1 | 1 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 0.1995 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | EC50 | 0.1995 | 1 | 1 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | EC50 | 0.1995 | 1 | 1 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | EC50 | 0.1995 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 1.3000 | 1 | 1 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | Kd | 0.2550 | 2 | 2 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | Kd | 324.1420 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | EC50 | 0.4000 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | EC50 | 0.1200 | 1 | 1 |
| N-arachidonyl glycine receptor | Homo sapiens (human) | EC50 | 4.6100 | 1 | 1 |
| NPYLR7B | Aedes aegypti (yellow fever mosquito) | EC50 | 20.0000 | 1 | 1 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Kd | 0.1090 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 18.9333 | 3 | 3 |
| Protease | Human immunodeficiency virus 1 | Kd | 0.5770 | 1 | 1 |
| Sialic acid-binding Ig-like lectin 7 | Homo sapiens (human) | Kd | 680.0000 | 1 | 1 |
| streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 0.0600 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | EC50 | 0.2300 | 1 | 1 |
| tRNA (cytosine(38)-C(5))-methyltransferase | Homo sapiens (human) | Kd | 13.6000 | 1 | 1 |
| tRNA (guanine-N(1)-)-methyltransferase | Mycobacterium tuberculosis H37Rv | Kd | 10.1000 | 1 | 1 |
| tRNA (guanine-N(1)-)-methyltransferase | Pseudomonas aeruginosa PAO1 | Kd | 5.9000 | 1 | 1 |
| tRNA (guanine-N(1)-)-methyltransferase | Staphylococcus aureus subsp. aureus NCTC 8325 | Kd | 3.3000 | 1 | 1 |
| Type 1 fimbrin D-mannose specific adhesin | Escherichia coli K-12 | Kd | 2.3000 | 1 | 1 |